Debt to Equity Ratio Chart

View Debt to Equity Ratio for NVNO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.0244
March 31, 2026 0.0254
December 31, 2025 0.0258
September 30, 2025 0.0269
June 30, 2025 0.0267
March 31, 2025 0.0256
December 31, 2024 0.0252
September 30, 2024 0.0242
June 30, 2024 0.0321
March 31, 2024 0.0311
December 31, 2023 0.0303
September 30, 2023 0.0594
June 30, 2023 0.0541
March 31, 2023 0.048
December 31, 2022 0.0443
September 30, 2022 0.0419
June 30, 2022 0.04
March 31, 2022 0.0377
December 31, 2021 0.0369
Date Value
September 30, 2021 0.0057
June 30, 2021 0.0177
March 31, 2021 0.0186
December 31, 2020 0.1241
September 30, 2020 0.1987
June 30, 2020 2.775
March 31, 2020 -54.13
December 31, 2019 0.8653
September 30, 2019 0.2993
June 30, 2019 0.2127
March 31, 2019 0.3684
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 -0.4444
December 31, 2017 -0.4394
September 30, 2017 -0.4644
December 31, 2016 -2.230

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Abbott Laboratories 0.638
AngioDynamics, Inc. 0.0641
Alphatec Holdings, Inc. 52.37
AtriCure, Inc. 0.1437
Baxter International, Inc. 1.427